ADC Therapeutics (ADCT) Return on Sales (2021 - 2026)
ADC Therapeutics (ADCT) posted Return on Sales of 0.02% for Q1 2026, up 36.6% sequentially from 0.02% in Q3 2025, and little changed YoY from 0.02% in Q1 2025.
ADC Therapeutics (ADCT) Return on Sales (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Return on Sales for 6 years, with the latest figure at 0.02% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 0.00% |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 0.00% |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 0.00% |
| 10 | ADC Therapeutics | 151.40 Mn | -67.70 Mn | 17.14 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | 0.00% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -0.19% |